Developing an evidence-based methodological framework to systematically compare HTA coverage decisions: A mixed methods study
Authors:
Open Access
- 1 January 2016
- journal article
- research article
- Published by Elsevier in Health Policy
- Vol. 120 (1) , 35-45
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- A REVIEW OF HEALTH TECHNOLOGY APPRAISALS: CASE STUDIES IN ONCOLOGYInternational Journal of Technology Assessment in Health Care, 2012
- Commonalities and differences in HTA outcomes: A comparative analysis of five countries and implications for coverage decisionsHealth Policy, 2012
- Access to orphan drugs despite poor quality of clinical evidenceBritish Journal of Clinical Pharmacology, 2010
- EBM, HTA, and CER: Clearing the ConfusionThe Milbank Quarterly, 2010
- Using Effectiveness and Cost-effectiveness to Make Drug Coverage DecisionsJAMA, 2009
- Methods, procedures, and contextual characteristics of health technology assessment and health policy decision making: Comparison of health technology assessment agencies in Germany, United Kingdom, France, and SwedenInternational Journal of Technology Assessment in Health Care, 2009
- Centralized Drug Review Processes In Australia, Canada, New Zealand, And The United KingdomHealth Affairs, 2006
- The development of health technology assessmentHealth Policy, 2003
- BEST PRACTICE IN UNDERTAKING AND REPORTING HEALTH TECHNOLOGY ASSESSMENTSInternational Journal of Technology Assessment in Health Care, 2002
- A Coefficient of Agreement for Nominal ScalesEducational and Psychological Measurement, 1960